FOG13481
EOG8HX3M8
sce:RGI1;RGI2
Genes: 27
SGD DescriptionProtein of unknown function; involved in energy metabolism under respiratory conditions; protein abundance is increased upon intracellular iron depletion or in response to DNA replication stress; RGI1 has a paralog, RGI2, that arose from the whole genome duplication|Protein of unknown function; involved in energy metabolism under respiratory conditions; expression induced under carbon limitation and repressed under high glucose; RGI2 has a paralog, RGI1, that arose from the whole genome duplication
References
Bammert GF, et al. (2000 May). Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol.
Rogers PD, et al. (2003 Apr). Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates.
Peng J, et al. (2003 Aug). A proteomics approach to understanding protein ubiquitination.
Boer VM, et al. (2003 Jan 31). The genome-wide transcriptional responses of Saccharomyces cerevisiae grown on glucose in aerobic chemostat cultures limited for carbon, nitrogen, phosphorus, or sulfur.
Harcus D, et al. (2004 Oct). Transcription profiling of cyclic AMP signaling in Candida albicans.
Lai LC, et al. (2005 May). Dynamical remodeling of the transcriptome during short-term anaerobiosis in Saccharomyces cerevisiae: differential response and role of Msn2 and/or Msn4 and other factors in galactose and glucose media.
Kresnowati MT, et al. (2006). When transcriptome meets metabolome: fast cellular responses of yeast to sudden relief of glucose limitation.
Seo HY, et al. (2008 Aug). Proteomic analysis of recombinant Saccharomyces cerevisiae upon iron deficiency induced via human H-ferritin production.
Rosenbach A, et al. (2010 Jul). Adaptations of Candida albicans for growth in the mammalian intestinal tract.
Domitrovic T, et al. (2010 Jun 17). Structural and functional study of YER067W, a new protein involved in yeast metabolism control and drug resistance.